enasidenib (idhifa) Report issue

Small molecule Orphan Drug FDA Approved FDA First in Class Fast Track FDA Priority Review FDA
AACT DrugBank Drugs@FDA PubChem
Back

Drug Pricing Summary

VA Big4

$628.6120 - $636.7133

VA FSS

$827.7550

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
enasidenib mesylate 100 mg (TABLET) $636.7133 VA Big4
  • Idhifa (30)
    		•  Celgene Corporation
    enasidenib mesylate 100 mg (TABLET) $827.7550 VA FSS
  • Idhifa (30)
    		•  Celgene Corporation
    enasidenib mesylate 50 mg (TABLET) $628.6120 VA Big4
  • Idhifa (30)
    		•  Celgene Corporation
    enasidenib mesylate 50 mg (TABLET) $827.7550 VA FSS
  • Idhifa (30)
    		•  Celgene Corporation

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue